YbdY will be a leading cytokine therapeutics company in the biotechnology industry. Since 2009, the company has tapped the knowledge of scientific discovery and innovation to improve the practice of medicine.
YbdY will be a pioneer to develop novel products based on advances in genetics and molecular biology and launched the biotechnology industry’s cytokine-based blockbuster therapy. YbdY continues to be an entrepreneurial, science-based enterprise dedicated to helping patients having serious illness.
